High-Efficiency Retroviral Transduction of Mammalian Cells on Positively Charged Surfaces
- 1 January 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (1) , 43-51
- https://doi.org/10.1089/10430340050016148
Abstract
The efficiency of retroviruses as transducing agents has been appreciated for many years, particularly for hematopoietic cell targets for which alternative strategies applicable to adherent cells are not effective. Advances in vector design, pseudotyping, and infection conditions have eliminated the need to cocultivate the target cells with virus-producing cells. Nevertheless, improvements are still needed for many applications, including those with a therapeutic or clinical cell-tracking objective. In this study we show that more positively charged surfaces, including those designed for the culture of anchorage-dependent cells, allow measurable levels of adhesion by different pseudotypes of retroviruses, which can result in increased gene transfer efficiencies to a variety of target cells including normal primary human hematopoietic cells as well as human leukemic cell lines and rat and murine fibroblasts. In the experiments with primary human cells, equal aliquots of enriched CD34+ cord blood cells were first stimulated for 2 days with cytokines (Flt3 ligand, Steel factor, IL-3, IL-6, and G-CSF) and then exposed for 4 days to a green fluorescent protein (GFP)- and Neor-encoding retrovirus produced in PG13 cells. Both the final yield (300% relative to initial numbers), and the proportion (60%) of transduced CD34+ cells, colony-forming cells, and long-term culture-initiating cells were the same for cells infected either in tissue culture dishes or in fibronectin-coated petri dishes. Similar proportions (10%) and absolute yields of GFP+ human cells were also found in multilineage engrafted NOD/SCID mice assessed 6 to 8 weeks after being transplanted with these two types of transduced, but unselected, cells. These findings suggest a new and simpler approach for achieving high gene transfer efficiencies to hematopoietic cells.Keywords
This publication has 39 references indexed in Scilit:
- Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrowExperimental Hematology, 1999
- High-Level Gene Transfer to Cord Blood Progenitors Using Gibbon Ape Leukemia Virus Pseudotype Retroviral Vectors and an Improved Clinically Applicable ProtocolHuman Gene Therapy, 1998
- Virosomes: Cationic Liposomes Enhance Retroviral TransductionNature Biotechnology, 1996
- Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.Journal of Clinical Investigation, 1994
- Improved Methods of Retroviral Vector Transduction and Production for Gene TherapyHuman Gene Therapy, 1994
- Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease.The Journal of Experimental Medicine, 1993
- Report to the NIH Recombinant DNA Advisory Committee on Murine Replication-Competent Retrovirus (RCR) Assays (February 17, 1993)Human Gene Therapy, 1993
- Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.Journal of Clinical Investigation, 1992
- The total marrow mass of the mouse: A simplified method of measurementAmerican Journal of Hematology, 1984
- A Membrane Effect of Basic Polymers dependent on Molecular SizeNature, 1967